disease

Alzheimer's disease: the FDA approves a new anti-amyloid antibody

Alzheimer’s disease: the FDA approves a new anti-amyloid antibody

Washington, United States — Lecanemab (Lequembi®, Eisai), an anti-amyloid beta protofibril antibody, has been approved by the Food and Drug Administration (FDA) in the treatment of Alzheimer’s disease. This is the second antibody targeting amyloid β plaques to receive marketing authorization in this indication. Like the controversial aducanumab (Aduhelm®, Biogen/Eisai), lecanemab was approved under an …

Alzheimer’s disease: the FDA approves a new anti-amyloid antibody Read More »

Does the flu vaccine protect us against Alzheimer's disease?  A study reveals that it reduces the risk by 40%!

Does the flu vaccine protect us against Alzheimer’s disease? A study reveals that it reduces the risk by 40%!

Many efforts are being made to develop a cure for Alzheimer’s disease. But until today, many promising treatments in animals have subsequently failed in clinical trials. Regarding the progress of vaccines, they are very slow. But several studies suggest that part of the cure may have been under our noses for decades in the form …

Does the flu vaccine protect us against Alzheimer’s disease? A study reveals that it reduces the risk by 40%! Read More »